Article
Considerations on patient-related outcomes with the use of botulinum toxins: is switching…
Therapeutics and Clinical Risk Management · 2016 · Fraint A, Vittal P, Comella C
Key facts
| Title | Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe? |
|---|---|
| First author | Fraint A, Vittal P, Comella C |
| Journal | Therapeutics and Clinical Risk Management |
| Published | Feb 5, 2016 |
| DOI | 10.2147/TCRM.S99239 |
| Product codes mentioned | DQO, GAD |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1